Roche
-
Sarepta , Roche halt DMD gene therapy Elevidys for non-ambulatory patients
This decision follows a safety re-assessment after two non-ambulatory patients treated with Elevidys died from acute liver failure (ALF), a serious side effect linked to the therapy.
-
Roche invests US$700M in new biologics plant in North Carolina
This 700,000 square-foot plant will focus on producing biologic medicines, particularly next-generation obesity drugs, for Genentech, a member of the Roche Group.
-
SRTIP partners with Roche Diagnostics to drive sustainable healthcare innovation in Sharjah
Through this MoU, Roche Diagnostics and the Sharjah Research, Technology, and Innovation Park (SRTIP) will collaborate to use biotechnology, digital health, and artificial intelligence to enable personalized medicine and improve the region’s healthcare capabilities.
-
Roche announces massive US$50B expansion plan in the United States
The investment aims to create more than 12,000 new jobs nationwide, including nearly 6,500 construction roles and 1,000 permanent positions at new and expanded facilities.
-
Study suggests Gantenerumab could prevent inherited Alzheimer’s onset
The latest data from the OLE study, published in The Lancet, revealed that the anti-amyloid drug cut the risk of developing Alzheimer’s symptoms by 50%.
-
-
-
-
-
